“…Using high throughput screening and rational design, our laboratory identified bridged tetrahydroquinolines as specific Nox2 inhibitors [191]. Among a group of structurally related molecules, compounds 11 g [(±)-(1S,4R,9S)-5-bromo-3,3-dimethyl-9-(2-methylallyl)−10-pentyl-1,2,3,4-tetrahydro-1,3-(epiminomehono) naphthalene] and 11 h [(±)-(1S,4R,9S)-5-bromo-3,3-dimethyl-9-(2-methyallyl)-10-(thiophen-2-ylmethyl)-1,2,3,4-tetrahydro-1,4-(epino-methano)naphthalene] displayed isoform-selective inhibition on Nox2 in intact COS-Nox2 cells with IC 50 of 20 μM and 32 μM, respectively.…”